SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001415889-24-004493
Filing Date
2024-02-20
Accepted
2024-02-20 19:35:11
Documents
1
Period of Report
2024-02-13

Document Format Files

Seq Description Document Type Size
1 form4a-02212024_120239.html 4/A  
1 form4a-02212024_120239.xml 4/A 4497
  Complete submission text file 0001415889-24-004493.txt   5985
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 720-647-8519
Enliven Therapeutics, Inc. (Issuer) CIK: 0001672619 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CORMORANT ASSET MANAGEMENT, LLP 200 CLARENDON STREET, FL 52 BOSTON MA 02116
Business Address
Phillips Andrew John (Reporting) CIK: 0001921956 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-39247 | Film No.: 24655867